DNER and cancer: However, clinical trials for BET inhibitors in pediatric cancers remain limited, with only one ongoing trial (NCT03936465), including pediatric solid tumors or lymphoma in the first arm, and pediatric brain tumors or tumors that have metastasized to the brain in the second arm.